Login Contact Us
Jan 2020, Vol 8, Issue 1
Advanced Search
Title
Authors
Keyword
Poll
How do you find the scientific quality of the published articles on our web site?


Original Article
The Utility of CA125 and HE4 in Patients Suffering From Endometrial Cancer
Narges Zamani1, Mitra Modares Gilani2, Majid Mirmohammadkhani3, Sharzad Sheikhhasani2, Azamsadat Mousavi2, Seyedeh Reyhaneh Yousefi Sharami4, Setare Akhavan2, Mohammad Hossein Zamani1, Elham Saffarieh5
1Department of Gynecology and Obstetrics, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
23Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
4Department of Obstetrics and Gynecology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
5Abnormal Uterine Bl>eeding Research Center, Semnan University of Medical Sciences, Semnan, Iran

IJWHR 2020; 8: 095-100
DOI: 10.15296/ijwhr.2020.14
Viewed : 502 times
Downloaded : 602 times.

Keywords : Endometrial cancer, Human epididymis 4, Cancer antigen 125
Full Text(PDF) | Related Articles
Abstract
Objectives: Uterine endometrial cancer (EC) is the most common female reproductive system malignancy. There are various comments on pelvic and para-aortic lymphadenectomy during the surgical staging of EC. Several oncologists believe that total lymphadenectomy, in some cases, may lead to operative morbidity without any considerable advantage over more surveillance, especially in patients with comorbidities. The purpose of the current study was to examine the correlation between serum tumor marker levels and stage, grade, histological type, myometrial invasion, and lymph node involvement in EC.

Materials and Methods: A total of 131 patients with EC participated in the present cross-sectional study. Preoperative serum CA125 and HE4 levels were evaluated 1 week before surgery. Then, the stage, grade, and lymph node involvement were recorded according to the pathological findings. After Data analysis through SPSS software, P value<0.05 was considered to be significant.

Results: One hundred thirty-one patients with EC (70, 31, 15, and 15 patients in sequence with stages IA, IB, II, and III) were analyzed. The serum CA125 and HE4 levels were significantly higher in more advanced stages (over IA), (P = 0.016 and P = 0.004, respectively). Levels of both tumor markers were significantly higher in patients with lymph node involvement, and cervical and myometrial invasions. In logistic regression analysis, a significant correlation was found between HE4 level (odds ratio [OR] = 1.005, P = 0.035) and grade of disease (OR = 2.137, P = 0.005).

Conclusions: HE4 and CA125 are useful for predicting high-risk patients. Sensitivity of 64% and specificity of 60% were indicated at cut-off value of 70 pmol/L for HE4 in stage IA in comparison with stages over IA. Although the ideal cut-off which is defined as higher than 80% was not obtained, such a cut-off (60%) can also be considered for preoperative evaluation of surgical staging of EC.

Cite By, Google Scholar

Google Scholar

Articles by Zamani N
Articles by Modares Gilani M
Articles by Mirmohammadkhani M
Articles by Sheikhhasani S
Articles by Mousavi A
Articles by Akhavan S
Articles by Hossein Zamani M
Articles by Saffarieh E

PubMed

Articles by Narges Zamani
Articles by Azamsadat Mousavi
Articles by Setare Akhavan
Articles by Elham Saffarieh

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics